Franco. Thanks ended On strong financial results. slide XX, we XXXX with
and For segments, the in or value constant to a XX% to driven by increased high the fourth revenue quarter, on growth €XXX.X XX% currency solutions million both basis, currency. shift
and results expected for certain from to top-line better XXXX. This were the revenue forecasted QX Covid-XX. projects recognition in revenue of quarter due Our previously the that includes was fourth than Engineering
forecast total revenue. from revenue XX% was of than our and result, represented higher Covid-XX a As
We which are to fourth of €XX.X increased progress million high growing making mix relevant the quarter. our value in solutions, XX%
profit inflationary by XXX due higher costs. margin to revenue, gross the For and to fourth the basis favorable mix, a recovery costs XX.X%, fixed increased points of of better quarter, leverage
increased in Operating XX.X% a margin benefit of to other quarter the joint in development profit to included project. million €X related and a income,
on plants, with in was profit year. costs XX.X%, the margin new start-up same operating XX.X% compared adjusted Excluding the last period
A adjusted of cents, points cents reflecting earnings million, million EPS €XX.X On million, adjusted the which €XX.X over last better-than-expected bottom margin profit and in: share, net adjusted an X.XX line, XXX or this XX basis net diluted or profit of per EBITDA year. of EBITDA diluted XX%, €XX.X adjusted was of totaling resulted up
driven growth to year year. full both mix the value constant revenue XX, basis, XX% by increased currency €XXX.X slide currency. to to on in Turning solutions XX% segments, On high basis, last revenue a and grew a million, shift over
in from lower growth full in partially year revenue revenue by XXXX. As was COVID-XX to offset of XX% revenue total compared expected, represented XX% which XXXX,
revenue from off, of As have we rolls across decrease been areas. projects broad range with successfully backfilling COVID-XX this new a therapeutic
and approximately solutions of XX% of €XXX.X grew a million high XXXX, represented revenue. to For value record XX%
Our operational efficiencies for solid to and the full growth, favorable expanding mix led margins year. shift,
despite XXXX As points gross XXX result, increased XX.X%, for profit inflation. a basis margin to
inflationary we it costs recovered of the to gross XXXX. price in nearly adjustments, While dilutive effect through profit a margin had all
XXXX For XX.X%. full to operating points profit for basis up the XX fiscal was year, margin
XX.X%, new XX.X% operating margin start-up costs the to Excluding on increased to adjusted last plants, compared year. profit
On the line million net bottom increased on of XX% of earnings €XXX delivery EPS to XXXX. with diluted cents. adjusted diluted per solid to for profit an XX led share XX cents This or basis
For XXXX, in an resulting €XXX.X XX% increased of adjusted XX.X%. margin million EBITDA to adjusted EBITDA
and and full quarter segment to XX. Segment on move results fourth results Slide Biopharmaceutical Solutions once Diagnostic again The Let’s year. the delivered for strong
in high the For costs. over the million, basis margin increased leverage Operating XX% revenue a value was to and revenue for prior of containment due the mix, the was in and profit recovery Segment XX.X% the mainly €XXX.X fourth growth constant solutions. to a profit the of costs, and fixed a In quarter, margin and increased XX% gross from other solutions to increase inflationary better XX% favorable XX% currency Revenue strong delivery generation, driven XX.X% by year. increase quarter. QX, on
to a grew while and the million, For the value XX% compared prior Revenue basis, other grew solutions full XX% year, €XXX.X and X% on high year. over constant containment fiscal was XX%, with from XXXX. up delivery currency revenue
segment year, full to margin operating headwinds. XXX XX.X%, the for XX.X%, For basis gross inflationary profit increased to and BDS profit despite the improved points margin
the the million, €XX.X the Engineering timing due Segment for and progression mostly of fourth revenue better than in expected projects. were to increased Financial and XX% results to quarter
business revenue lines. in XX% year, increased all to €XXX.X driven full the million For by growth
mix, basis XX.X%, For profit operating and mostly margin XX.X%. margin the points to XX fourth quarter profit of due XXXX, project gross decreased to was
gross For from year, XX.X% points business driven business improved basis by as optimization mainly as margin ongoing contributions efforts. more full accretive the profit well XXX to lines,
improved margin operating a As result, XX.X% profit to
had On cash million, slide XXXX, equivalents financial we position and cash December of net million. €XX €XXX.X of XX, a positive as XXst, of and
from higher This working €XXX.X fiscal year, in risk. of flow totalled for capital million to increased Meanwhile, full used €XXX for million support investing, generated resulted the negative to reflecting free support growth mitigate plans. XXXX. our to expansion cash was cash For operating and million, activities €XXX chain cash inventories supply net
totaling XXXX, in million February loans €XXX growth of investments In secured our platforms. two for we ongoing
for through The first €XX was Paribas financed million. loan five-year BNP
draw loan financed can was capital when access a Depositi through needed. e Cassa Prestiti. the The so for we million second have €XX loans Both two-year down
up balance shore and loans for provide capital The flexibility deployment. sheet, added our us
is have Our to future and healthy, we balance sheet we growth. adequate fund believe liquidity
global on million to €XXX.X CapEx, we capital invest XXXX, XX. expenditures In were slide to strategic as Turning in our expansion. continued
U.S. from XXXX, the demand. focusing rising million As €XX and in of we expenditures of efforts Italy, Franco of revenue our are which is on capital carry-over to XX% Consequently, XXXX. we capitalize are XX% fiscal to forecasting approximately noted, in
our approximately XXXX, all tied growth, activities of including XX% For expected for balance and other to the remaining is R&D. CapEx
Let’s XX. review guidance on page
cents XX This is growth diluted estimated to COVID, XX XX%; XXXX, to Adjusted in of the implies in of fiscal Excluding greater the million range growth EPS Revenue between of XX%, range to €X.XXX billion. billion €XXX.X range the be we €XXX.X to Adjusted For €X.XXX XX% and than cents, in EBITDA expect million,
first Our results XXXX our considers assumes that half year. we stronger and the growth and the following: headwinds will will be linear tailwinds, the be than and half, throughout guidance First, expect second
Our model in assumes growth and high-single-digit double-digit Segment Engineering. the growth BDS in
a in Consistent the QX down expect revenue XXXX. compared with step quarter, with prior in years, we first
solutions currency by We forecasted that a high €XX have lastly, are million million X% revenue. represent XXXX value estimating revenue. versus will of XXXX to decrease to assumed we COVID-XX about Revenue X% We million. it of XX% €XX And will in XX% approximately estimate to from that represent approximately €XX XXXX. expected approximately headwind to of is
I comments. will the to Thank Franco hand you, closing call for
